Acute peritoneal dialysis: What is the 'adequate' dose for acute kidney injury?

Nephrology Dialysis Transplantation

Volumn 25, Issue 10, 2010, Pages 3155-3160

  Chionh, Chang Yin ^a,b   Ronco, Claudio ^a,c   Finkelstein, Fredric O ^d   Soni, Sachin S ^a,e   Cruz, Dinna N ^a,c  

^a SAN BORTOLO HOSPITAL   (Italy)

^b CHANGI GENERAL HOSPITAL   (Singapore)

^c International Renal Research Institute Vicenza (IRRIV)   (Italy)

^d YALE UNIVERSITY   (United States)

^e Seth Nandlal Dhoot Hospital   (India)

Author keywords

acute kidney injury; clearance; dose of dialysis; peritoneal dialysis; urea kinetic modelling

Indexed keywords

IMMUNOGLOBULIN; OPSONIN;

DOSE CALCULATION; HUMAN; KIDNEY CLEARANCE; KIDNEY INJURY; MOLECULAR WEIGHT; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEIN DEPLETION; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; ULTRAFILTRATION;

ACUTE KIDNEY INJURY; HUMANS; PERITONEAL DIALYSIS; UREA;

EID: 77957245931     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq178     Document Type: Review

References (56)

1. Overberger P, Pesacreta M, Palevsky PM. Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices. Clin J Am Soc Nephrol 2007; 2: 623-630
2. Ricci Z, Ronco C, D'Amico G et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 2006; 21: 690-696
3. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006; 2: 364-377
4. Cerda J, Bagga A, Kher V et al. The contrasting characteristics of acute kidney injury in developed and developing countries. Nat Clin Pract Nephrol 2008; 4: 138-153
5. Lameire N, Vanholder R, Clement J et al. The organization of the European Renal Disaster Relief Task Force. Ren Fail 1997; 19: 665-671
6. Vanholder R, van Biesen W, Lameire N et al. The role of the International Society of Nephrology/Renal Disaster Relief Task Force in the rescue of renal disaster victims. Contrib Nephrol 2007; 156: 325-332
7. Kleinpeter MA. End-stage renal disease use in hurricane-prone areas: should nephrologists increase the utilization of peritoneal dialysis? Adv Chronic Kidney Dis 2007; 14: 100-104
8. Collins AJ, Burzstein S. Renal failure in disasters. Crit Care Clin 1991; 7: 421-435
9. Noji EK. Natural disasters. Crit Care Clin 1991; 7: 271-292
10. Eknoyan G. Acute renal failure in the Armenian earthquake. Ren Fail 1992; 14: 241-244
11. Sever MS, Erek E, Vanholder R et al. The Marmara earthquake: epi-demiological analysis of the victims with nephrological problems. Kidney Int 2001; 60: 1114-1123
12. Sever MS, Vanholder R, Lameire N. Management of crush-related injuries after disasters. N Engl J Med 2006; 354: 1052-1063
13. Gabriel DP, Caramori JT, Martim LC et al. High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury. Kidney Int 2008; 73: S87-S93
14. Moist LM, Port FK, Orzol SM et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556-564
15. Lysaght MJ, Vonesh EF, Gotch F et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37: 598-604
16. Rottembourg J, Issad B, Gallego JL et al. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant As-soc 1983; 19: 397-403
17. Cancarini G, Bunori G, Camerini C et al. Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perit Dial Bull 1986; 6: 77-79
18. Stenvinkel P, Chung SH, Heimburger O et al. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int 2001; 21: S157-S162
19. Haubitz M, Brunkhorst R, Wrenger E et al. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit Dial Int 1996; 16: 158-162
20. Takahashi T, Kubota M, Nakamura Tet al. Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Ren Fail 2000; 22: 345-354
21. De Cal M, Cruz DN, Corradi Vet al. HLA-DR expression and apop-tosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients. Blood Purif 2008; 26: 249-254
22. Mehta RL, Letteri JM. Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on Dialysis. Am J Nephrol 1999; 19: 377-382
23. Chitalia VC, Almeida AF, Rai H et al. Is peritoneal dialysis adequate for hypercatabolic acute renal failure in developing countries? Kidney Int 2002; 61: 747-757
24. Palevsky PM, Zhang JH, O'Connor TZ et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20
25. Bellomo R, Cass A, Cole L et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-1638
26. Ricci Z, Ronco C. Dose and efficiency of renal replacement therapy: continuous renal replacement therapy versus intermittent hemodialysis versus slow extended daily dialysis. Crit Care Med 2008; 36: S229-S237
27. Ronco C, Kellum JA, Bellomo R et al. Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 531-544
28. Schiffl H. Utility of urea kinetic modelling for prescription of adequate intermittent dialysis in critically ill maintenance dialysis patients. Nephrol Dial Transplant 2007; 22: 2096
29. Himmelfarb J, Evanson J, Hakim RM et al. Urea volume of distribution exceeds total body water in patients with acute renal failure. Kidney Int 2002; 61: 317-323
30. Kanagasundaram NS. Prescription of an intermittent haemodialysis dose using urea kinetic modelling is feasible in the critically ill patient. Nephrol Dial Transplant 2008; 23: 1075
31. Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998; 13: 10-14
32. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48: S2-S90
33. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 2006; 48: S98-S129
34. Kellum JA. Renal replacement therapy in critically ill patients with acute renal failure: does a greater dose improve survival? Nat Clin Pract Nephrol 2007; 3: 128-129
35. Paganini EP TM, Goormastic M et al. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 1996; 28: S81-S89
36. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-310
37. Zemel D, Imholz AL, de Waart DR et al. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994; 46: 1422-1430
38. Sethi D, Murphy CM, Brown EA et al. Clearance of beta-2-micro-globulin using continuous ambulatory peritoneal dialysis. Nephron 1989; 52: 352-355
39. Steiner RW. Continuous equilibration peritoneal dialysis in acute renal failure. Perit Dial Int 1989; 9: 5-7
40. Passadakis PS, Oreopoulos DG. Peritoneal dialysis in patients with acute renal failure. Adv Perit Dial 2007; 23: 7-16
41. Evenepoel P, Bammens B, Verbeke K et al. Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis. Kidney Int 2006; 70: 794-799
42. Brophy DF, Sowinski KM, Kraus MA et al. Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis. Perit Dial Int 1999; 19: 534-539
43. Bagshaw SM, Brophy PD, Cruz D et al. Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit Care 2008; 12: 169
44. Wiedemann HP, Wheeler AP, Bernard GR et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-2575
45. Dimkovic N, Oreopoulos DG. Chronic peritoneal dialysis in the elderly. Semin Dial 2002; 15: 94-97
46. Krishnan A, Oreopoulos DG. Peritoneal dialysis in congestive heart failure. Adv Perit Dial 2007; 23: 82-89
47. Chionh CY, Soni S, Cruz DN et al. Peritoneal dialysis for acute kidney injury: techniques and dose. Contrib Nephrol 2009; 163: 278-284
48. Gabriel DP, Nascimento GV, Caramori JTet al. High volume peritoneal dialysis for acute renal failure. Perit Dial Int 2007; 27: 277-282
49. Phu NH, Hien TT, Mai NT et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002; 347: 895-902
50. Howdieshell TR, Blalock WE, Bowen PA et al. Management of post-traumatic acute renal failure with peritoneal dialysis. Am Surg 1992; 58: 378-382
51. Verbrugh HA, Keane WF, Hoidal JR et al. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983; 147: 1018-1029
52. Lamperi S, Carozzi S, Icardi A et al. Peritoneal membrane defense mechanism in CAPD. Trans Am Soc Artif Intern Organs 1985; 31: 33-37
53. Steen S, Brenchley P, Manos J et al. Opsonising Capacity of Peritoneal Fluid and Relationship to Peritonitis in CAPD. In: WJ Maher JF (ed). Frontiers in Peritoneal Dialysis. New York: Field, Rich and Sccoc Inc, 1986; 656
54. Vas SI, Duwe A, Weatherhead J. Natural Defence Mechanism of the Peritoneum: The Effect of Peritoneal Dialysis Fluid on Polymorpho-nuclear Cells. In: RC Atkins, NM Thomson, PC Farell (eds). Peritoneal Dialysis. Edinburgh: Churchill Livinstone 1081
55. Alobaidi HM, Coles GA, Davies M et al. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1: 16-21
56. Piraino B, Bailie GR, Bernardini J et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-131